Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 38 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Medispar from Brussel, company number BE0875667302, closed financial year 2025 with a result of € -1.2 million after tax. For that financial year Medispar recorded a gross margin of € 153,283 and equity of € 471,959. Compared with financial year 2024, the result moved from € -156,191 to € -1.2 million. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
€ 471,959
▲ 103% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.2 million
▼ 641 % more loss than in 2024
Profit after tax over the fiscal year.
€ 40,302
▼ 62% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.1 million.
People and assets in 2025
4.1
▲ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 728,693
▲ 21% vs 2024
€ 177,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 5,168
▼ 44% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 200,000
▼ 85% vs 2024
Loans from banks and other lenders, long and short.
€ 500,434
▼ 11% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 107,858
▼ 76% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 1,078,450 | € 2,259,906 | € 846,021 | € 153,283 | ▼ 82% |
| Profit after taxes | € 534,261 | € 1,548,214 | € -156,191 | € -1,157,639 | ▼ € 1 million |
| Equity | € 1,446,478 | € 388,692 | € 232,501 | € 471,959 | ▲ 103% |
| Total debts | € 3,556,078 | € 5,075,109 | € 3,701,804 | € 2,250,982 | ▼ 39% |
| Cash | € 917,132 | € 755,277 | € 106,609 | € 40,302 | ▼ 62% |
| Retained profit | € 1,283,086 | € 225,300 | € 69,109 | € -1,088,529 | ▼ € 1.2 million |
| Dividend | € 900,000 | € 2,606,000 | € 0 | € 0 | |
| Bank debt | € 1,632,068 | € 1,244,180 | € 1,311,160 | € 200,000 | ▼ 85% |
| Balance sheet total | € 5,002,556 | € 5,463,801 | € 3,934,304 | € 2,722,942 | ▼ 31% |
| Employees (FTE) | 2.3 | 3.4 | 4 | 4.1 | ▲ 0.1 |
Key figures of Medispar, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Medispar?
What happened at Medispar in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1.2 million. Source: NBB ↗
- Saesco Medical S.L. became a director. NBB
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
In short
From € 534,261 profit in 2022 to € 1.2 million loss in 2025.
Paid € 632,414 in corporate taxes since 2022.
Best year ever: 2023, with € 1.5 million profit.
On average € 37,400 of value added per employee in 2025.
A new publication or filing at Medispar? We notify you, reason included.
Follow MedisparDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Medispar is Saesco Medical S.L.. It owns 100% of Healthcare Marketing Services S.O.O. and 100% of Pelvitec B.V. (NL) itself.
Directors
According to the 2025 annual accounts
Saesco Medical S.L.
Director · represented by Fluvià Carreras Jordi
since 2022
Establishments
Establishment units
Physical locations of this company
Koloniënstraat 11
1000 Brussel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0875.667.302
- VAT number
- BE 0875.667.302
- Registered office
- Koloniënstraat 11, 1000 Brussel
- Names & denominations
- Medispar
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 August 2005
- Peppol
- Active · Active since 20 Apr 2026
- Activities · NACE
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering